Cash Flow Statement

Daily Values

Income Statement

Consolidated Net Income Cost of Revenue EBIT EBITDA EBT EPS (Basic)Gross Profit Income from Continuing Operations Income towards Parent Company Net Income towards Common Stockholders Operating Expenses Operating Income Profit After Tax Research & Development Revenue Selling, General & Administrative Shares Outstanding Shares Outstanding (Weighted Average)

Others

Ratios

Immuron (IMRN) Research & Development (2023)

Immuron has reported Research & Development over the past 1 years, most recently at $148106.7 for Q2 2023.